Additionally, GLO1 inhibitors have been used as adjunct therapies in cancer chemotherapy to counteract multidrug resistance.[72] Clinical evaluations have shown promising results in targeting glioblastoma multiforme and breast cancer, indicating its capacity for anti‐tumor therapy.[74] Besides, our in vitro experiments confirmed their potential use in cancer therapy. The gene discussed is GLO1; the disease is breast cancer.